"
The Influence of Progesterone Gel Therapy in the Treatment of Fibrocystic Breast Disease"
written by Milena Brkic, Svetlana Vujovic, Maja Franic Ivanisevic, Miomira Ivovic, Milina Tancic Gajic, Ljiljana Marina, Marija Barac, Branko Barac, Alekasandar Djogo, Gabrijela Malesevic, Damir Franic,
published by
Open Journal of Obstetrics and Gynecology,
Vol.6 No.5, 2016
has been cited by the following article(s):
|
[1]
|
Преконцепційна профілактика порушень лактації у жінок із фіброзно-кістозною хворобою молочних залоз
|
|
2021 |
|
|
|
|
[2]
|
The Role of Insulin Resistance in Benign Breast Disease
|
|
Impact of Polycystic …,
2021 |
|
|
|
|
[3]
|
Avaliação de géis transdérmicos na veiculação da terapia da reposição hormonal
|
|
Research, Society and …,
2021 |
|
|
|
|
[4]
|
Динамика клинических симптомов фиброзно-кистозной мастопатии на фоне монотерапии препаратом трансдермального микронизированного …
|
|
2020 |
|
|
|
|
[5]
|
LC-MS/MS Method for Rapid Quantification of Progesterone in Rabbit Plasma and Its Application in a Pharmacokinetic Study of the Transdermal Formulation
|
|
2020 |
|
|
|
|
[6]
|
Оценка эффективности комплексной терапии доброкачественной дисгормональной дисплазии молочных желез (ДДДМЖ) у женщин репродуктивного …
|
|
2019 |
|
|
|
|
[7]
|
Mastopatía fibroquística:¿ son útiles los tratamientos empleados en mujeres en etapa premenopáusica?
|
|
2019 |
|
|
|
|
[8]
|
A Survey on Nutritional Pattern in Women with Breast Fibrocystic Changes in Isfahan City, Iran
|
|
Journal of Isfahan Medical …,
2018 |
|
|
|
|
[9]
|
Клиникофармакологический анализ лекарственных препаратов, наиболее часто применяемых для фармакотерапии фиброзно-кистозной мастопатии
|
|
2018 |
|
|
|
|
[10]
|
Медикаментозное лечение дисгормональных заболеваний молочной железы: доказанное и спорное
|
|
2018 |
|
|
|
|
[11]
|
Динамика клинических симптомов фиброзно-кистозной мастопатии на фоне трансдермаль-ного геля микронизированного прогестерона: результаты …
|
|
2018 |
|
|
|
|
[12]
|
Correction of hormonal imbalance in patients with diffuse forms of mastopathy–the basis of pathogenetic therapy and oncoprophylaxis
|
|
2018 |
|
|
|
|
[13]
|
Benign Breast Disease During Women's Life
|
|
Pre-Menopause, Menopause and Beyond,
2018 |
|
|
|
|
[14]
|
Clinical and pharmacological analysis of most commonly used drugs for the pharmacotherapy of fibrocystic breast disease
|
|
The Journal “Obstetrics and Gynecology” (Moscow),
2018 |
|
|
|
|
[15]
|
Эффективность трансдермального геля, содержащего микронизированный прогестерон, в лечении фиброзно-кистозной мастопатии. Результаты …
|
|
2016 |
|
|
|
|
[16]
|
Efficacy of micronized progesterone-containing transdermal gel in the treatment of fibrocystic mastopathy: Results of a Russian study
|
|
Akusherstvo i Ginekologiya/Obstetrics and Gynecology,
2016 |
|
|
|
|
[1]
|
Mastodynia: Current data on the causes, course, diagnosis, and treatment approaches. A review
Gynecology,
2023
DOI:10.26442/20795696.2023.3.202341
|
|
|
|
|
[2]
|
Impact of Polycystic Ovary, Metabolic Syndrome and Obesity on Women Health
ISGE Series,
2021
DOI:10.1007/978-3-030-63650-0_14
|
|
|
|
|
[3]
|
Preconception prevention of lactation disorders in women with fibrocystic breast disease
REPRODUCTIVE ENDOCRINOLOGY,
2021
DOI:10.18370/2309-4117.2021.58.97-100
|
|
|
|
|
[4]
|
LC-MS/MS Method for Rapid Quantification of Progesterone in Rabbit Plasma and Its Application in a Pharmacokinetic Study of the Transdermal Formulation
Journal of Analytical Methods in Chemistry,
2020
DOI:10.1155/2020/8889375
|
|
|
|
|
[5]
|
Pre-Menopause, Menopause and Beyond
ISGE Series,
2018
DOI:10.1007/978-3-319-63540-8_18
|
|
|
|